Form 4 for VCEL Vericel Corp
Accepted 2024-02-22 00:00:00 ET · period of report 2024-02-20 · accession 0001140361-24-009033 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-02-22 | 2024-02-20 | VCEL | ZERBE ROBERT L MD | Dir | S - Sale+OE | $50.01 | -722 | 23.4K | -3% | -$36.1K |
| DT | 2024-02-22 | 2024-02-20 | VCEL | ZERBE ROBERT L MD | Dir | M - OptEx | $3.74 | +722 | 24.1K | +3% | +$2,700 |
| DT | 2024-02-22 | 2024-02-20 | VCEL | ZERBE ROBERT L MD | Dir | M - OptEx | $0.00 | +722 | 3,278 | +28% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-20 | S | D | 722 | $50.01 | 23,395 | D | — | — | (F1) The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. |
| 2 | Common | Common Stock | 2024-02-20 | M | A | 722 | $3.74 | 24,117 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-02-20 | M | A | 722 | $0.00 | 3,278 | D | $3.74 · — to — | 722 Common Stock | (F2) These options, representing the right to purchase 4,000 shares, became exercisable in three installments, contingent upon continued service to the Company, with the first vesting date on March 20, 2015, which was the date on which the option was granted, and the final vesting date on May 1, 2015. (F3) These options, which were awarded on March 20, 2015, would otherwise expire and become forfeitable on March 20, 2025. |